CAS: 1509916-03-3
Cergutuzumab
CAS:1509916-03-3
Cergutuzumab amunaleukin (CEA-IL2v) is an immunocytokine directed against carcinoembryonic antigen (CEA) containing an IL2v-moiety with …
Ref: 3D-CLA1643
| Undefined size | To inquire |
Estimated delivery in United States, on Wednesday 6 Nov 2024
Cergutuzumab Amunaleukin
CAS:1509916-03-3
Cergutuzumab amunaleukin (CEA-IL2v) is an immunocytokine directed against carcinoembryonic antigen (CEA) containing an IL2v-moiety with …
Ref: 3D-CLA1643A
| Undefined size | To inquire |
Estimated delivery in United States, on Wednesday 6 Nov 2024
Cergutuzumab amunaleukin
CAS:1509916-03-3
Cergutuzumab amunaleukin (CEA-IL2v) is a CEA-targeted IL-2 variant immunocytokine for combination cancer immunotherapy with anti-tumor …
Purity:
SDS-PAGE: 98.0%；SEC-HPLC: 99.7% - SDS-PAGE:98.0%;SEC-HPLC:99.7%
Color and Shape:
Solid
Molecular weight:
162.05 kDa
Ref: TM-T76944
| 1mg | 389.00 € | ||
| 5mg | 989.00 € | ||
| 10mg | 1,615.00 € | ||
| 25mg | 2,385.00 € | ||
| 50mg | 3,238.00 € |
Estimated delivery in United States, on Monday 30 Dec 2024
